Training program for researchers studying rheumatic and musculoskeletal diseases
Official title: The Rheumatic and Musculoskeletal Disease Epidemiology and Outcomes Training Program at the University of North Carolina
Funded at Univ of North Carolina Chapel Hill · NIH-11080987 · Data updated 2026-11-12
This program at the University of North Carolina is training new researchers to better understand and find treatments for rheumatic and musculoskeletal diseases, so they can help improve the lives of people affected by these conditions.
Quick facts
| Grant type | Training grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Univ of North Carolina Chapel Hill NIH-funded |
| Lab location | 1 site (Chapel Hill, United States) |
| Project start | May 1, 2024 |
| Project end | April 30, 2029 |
| Funding year | 2025 |
| Award (this year) | $275,120 |
| NIH project number | 5T32AR082310-02 |
| Project ID | NIH-11080987 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for participation or benefit from this research include individuals affected by rheumatic and musculoskeletal diseases or those interested in the epidemiology of these conditions.
✕Less likely to help
Patients who do not have rheumatic or musculoskeletal diseases may not receive direct benefits from this research.
What this research studies
This program at the University of North Carolina aims to train independent researchers in the field of rheumatic and musculoskeletal diseases (RMDs). It focuses on understanding the causes, effects, and treatments of these conditions, which affect a significant portion of the population. The training will involve both predoctoral and postdoctoral trainees from diverse backgrounds, equipping them with the skills needed to lead future research in this area. By enhancing the workforce in RMD epidemiology and outcomes research, the program seeks to address the growing need for expertise in this field.
Why it matters
Potential benefit: If successful, this research could lead to improved understanding and management of rheumatic and musculoskeletal diseases, ultimately benefiting patients through better treatment options.
How similar studies have gone: Other training programs in similar fields have shown success in enhancing research capabilities and improving patient outcomes, indicating a positive precedent for this approach.
Where this research is happening
-
Univ of North Carolina Chapel Hill
Chapel Hill, United States Active
Researchers
- Principal investigator: Callahan, Leigh Fleming — Univ of North Carolina Chapel Hill
- Study coordinator: Callahan, Leigh Fleming
Related research
Other NIH-funded projects on the same topics.
-
A center for coordinating data related to heart and blood health.
This study is working on a new system to gather and analyze health information about heart and blood disorders, which could lead to better ways to diagnose and treat these conditions, ultimately helping patients like you.
-
Healthy work design and worker well-being
A multi-site program aims to improve the health and well-being of workers by studying how work design affects safety, stress, and quality of life.
-
Unified and fair multimodal learning for autoimmune diseases
A patient-friendly AI approach will combine many kinds of health data to improve diagnosis and personalized care for autoimmune diseases, including lupus.
-
Structural factors linking minimum wage, COVID-19, and community violence
A long-term study will explore whether higher minimum wages and pandemic-related economic factors are connected to changes in violence in US communities.
-
Non-invasive tears biomarker for early Alzheimer's in LMICs
A low-cost, tear-based biomarker approach aims to detect early Alzheimer’s disease in older adults in Peru and similar settings.
-
How HPV interacts with our cells' DNA damage system and its effect on cancer
This project looks at how high-risk HPV uses the body’s DNA repair machinery to replicate and potentially drive cancer, with the goal of finding new antiviral and cancer-fighting approaches for people affected by HPV-related diseases.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.